Vijay Hall

Bachelor of Medicine and Bachelor of Science,  The Johns Hopkins Hospital 

Location: Germany

Consulting Services

Pharma-CRO-Device IT-Web-Mobile Technology Scientific Writing Grant Submission

Areas Of Interest

Lipoid Proteinosis, Urbach-Wiethe Seizures, Convulsive Fragments, VHH Taka Amylase A Analytical Device, Microarray Cys Transfer RNA Acids, Succinic Revivon Naphuride Remediations, Environmental Diseases, Arterial Occlusive Person, Non-Mobile Depilations, Electrolytic HSP70 Heat Shock Proteins Chimerin Proteins Kingdom of Saudi Arabia Craniosynostoses Xylan Endo-1,3-beta-Xylosidase Medicines, Molecular Receptor, Interleukin 10 AP-2 gamma Protein Airport Spinal Subdural Hematomas Atypical Cervical Squamous Cells Industrial Factories Deficiency, Total Hexosaminidase Cherry Tree, Brazilian Carbon Tetrachloride Premedications Spanish American Wars Sphincter, Pyloric Pupil Nurses Christmas-Rose pADPr-Binding Motif Carcinomas, Thyroid Hyperargininemias Cholecystitis beta Adrenergic Receptor Kinase Disease, Dental Pulp Aqueducts, Sylvian

Professional Narrative

Dr. Vijay Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Harvard Med 1993
Assistant Professor, Harvard Med 1997

Education

Director Medicine, Yale School of Medicine 1987
Director Medicine, Harvard Medical School 2012

Referees


Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :